Availability: | |
---|---|
Quantity: | |
The hyaluronic acid found in joint fluid and cartilage acts as a lubricant and shock absorber.
The quality of hyaluronic acid deteriorates in osteoarthritis of the knee joint, reducing its ability to protect and lubricate the joint and tissues.
Runxin Biotech is a viscoelastic substance that is injected into the knee joint to treat mild to moderate osteoarthritis. It's a 100% biocompatibility injection made by highly concentrated, non-animal sourced HA.
Runxin Biotech lubricates and protects cells and tissues by mimicking and replacing the naturally occurring hyaluronic acid.
It is indicated for the treatment of pain in osteoarthritis (OA) of the knee in p atients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics (e.g., acetaminophen).
Treatment is simple: injection of 2 ml Runxin Biotech solution into the knee joint, once a week, for three consecutive weeks, with follow-up after 6 months if needed.
It has also been tested on hip, shoulder, ankle and temporomandibular joints, convenience of a single injection compared to multiple visits to the physician.
The hyaluronic acid found in joint fluid and cartilage acts as a lubricant and shock absorber.
The quality of hyaluronic acid deteriorates in osteoarthritis of the knee joint, reducing its ability to protect and lubricate the joint and tissues.
Runxin Biotech is a viscoelastic substance that is injected into the knee joint to treat mild to moderate osteoarthritis. It's a 100% biocompatibility injection made by highly concentrated, non-animal sourced HA.
Runxin Biotech lubricates and protects cells and tissues by mimicking and replacing the naturally occurring hyaluronic acid.
It is indicated for the treatment of pain in osteoarthritis (OA) of the knee in p atients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics (e.g., acetaminophen).
Treatment is simple: injection of 2 ml Runxin Biotech solution into the knee joint, once a week, for three consecutive weeks, with follow-up after 6 months if needed.
It has also been tested on hip, shoulder, ankle and temporomandibular joints, convenience of a single injection compared to multiple visits to the physician.